{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:21:49Z","timestamp":1794622909666,"version":"4.9.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Horizon 2020 Marie Sk\u0142odowska-Curie Actions programme within the PremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis (PARENT) project","award":["Grant number 956394"],"award-info":[{"award-number":["Grant number 956394"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00246-023-03123-y","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T16:02:31Z","timestamp":1676563351000},"page":"1377-1383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Versatility of Atrial Flow Regulator Device in Congenital Heart Disease: A Case Series"],"prefix":"10.1007","volume":"45","author":[{"given":"Enrico","family":"Piccinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Butera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"5","key":"3123_CR1","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/ejhf.2119","volume":"23","author":"C Paitazoglou","year":"2021","unstructured":"Paitazoglou C, Bergmann MW, \u00d6zdemir R et al (2021) One-year results of the first-in-man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study. Eur J Heart Fail 23(5):800\u2013810","journal-title":"Eur J Heart Fail"},{"key":"3123_CR2","doi-asserted-by":"publisher","first-page":"175394472091957","DOI":"10.1177\/1753944720919577","volume":"14","author":"C Paitazoglou","year":"2020","unstructured":"Paitazoglou C, Bergmann MW (2020) The atrial flow regulator: current overview on technique and first experience. Ther Adv Cardiovasc Dis 14:1753944720919577","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"1","key":"3123_CR3","doi-asserted-by":"publisher","first-page":"204589402198996","DOI":"10.1177\/2045894021989966","volume":"11","author":"K Sivakumar","year":"2021","unstructured":"Sivakumar K, Rohitraj GR, Rajendran M et al (2021) Study of the effect of Occlutech Atrial Flow Regulator on symptoms, hemodynamics, and echocardiographic parameters in advanced pulmonary arterial hypertension. Pulm Circ 11(1):2045894021989966","journal-title":"Pulm Circ"},{"issue":"1","key":"3123_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5603\/CJ.2019.0016","volume":"26","author":"A D\u0105browska-Kugacka","year":"2019","unstructured":"D\u0105browska-Kugacka A, Cie\u0107wierz D, \u017buk G (2019) Atrial flow regulator for severe drug resistant pulmonary arterial hypertension after congenital heart defect correction. Cardiol J 26(1):102\u2013104","journal-title":"Cardiol J"},{"issue":"14","key":"3123_CR5","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jaccas.2022.05.010","volume":"4","author":"G Hansmann","year":"2022","unstructured":"Hansmann G, Sabiniewicz A, Sabiniewicz R (2022) Atrial flow regulator for postcapillary pulmonary hypertension: first-in-human transcatheter AFR device implantations in RCM. JACC Case Rep 4(14):878\u2013884","journal-title":"JACC Case Rep"},{"issue":"8","key":"3123_CR6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1017\/S1047951118000720","volume":"28","author":"A Lehner","year":"2018","unstructured":"Lehner A, Schulze-Neick I, Haas NA (2018) Creation of a defined and stable Fontan fenestration with the new Occlutech Atrial Flow Regulator (AFR\u00ae). Cardiol Young 28(8):1062\u20131066","journal-title":"Cardiol Young"},{"issue":"8","key":"3123_CR7","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1017\/S1047951121000731","volume":"31","author":"E Pascall","year":"2021","unstructured":"Pascall E, Jones MI, Savis A et al (2021) Transcatheter creation of a pulmonary artery to left atrial fenestration in a failing Fontan circulation using the atrial flow regulator (AFR). Cardiol Young 31(8):1376\u20131379","journal-title":"Cardiol Young"},{"issue":"5","key":"3123_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/icvts\/ivy165","volume":"27","author":"L Manuri","year":"2018","unstructured":"Manuri L, Calaciura RE, De Zorzi A et al (2018) Atrial flow regulator for failing Fontan circulation: an initial European experience. Interact Cardiovasc Thorac Surg 27(5):761\u2013764","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"10","key":"3123_CR9","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1017\/S104795112100127X","volume":"31","author":"EO Aregullin","year":"2021","unstructured":"Aregullin EO, Samuel B, Vettukattil J (2021) Planned reduction in Fontan fenestration size using the atrial flow regulator. Cardiol Young 31(10):1690\u20131692","journal-title":"Cardiol Young"},{"issue":"1","key":"3123_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.32604\/CHD.2022.018590","volume":"17","author":"B O\u2019Callaghan","year":"2022","unstructured":"O\u2019Callaghan B, Zablah J, Vettukattil J (2022) Multi-Institutional US Experience of the Occlutech\u00a9 AFR device in congenital and acquired heart disease. Congenit Heart Dis 17(1):107\u2013116","journal-title":"Congenit Heart Dis"},{"issue":"2020","key":"3123_CR11","first-page":"8897101","volume":"23","author":"Z Khajali","year":"2020","unstructured":"Khajali Z, Ghaderian H, Firoozi A et al (2020) New horizon of intervention in congenital heart disease: AFR in a Complex cyanotic patient. Case Rep Cardiol 23(2020):8897101","journal-title":"Case Rep Cardiol"},{"issue":"3","key":"3123_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.cardfail.2020.11.006","volume":"27","author":"E Piccinelli","year":"2021","unstructured":"Piccinelli E, Castro-Verdes MB, Fraisse A et al (2021) Implantation of an atrial flow regulator in a child on venoarterial extracorporeal membrane oxygenator as a bridge to heart transplant: a case report. J Card Fail 27(3):364\u2013367","journal-title":"J Card Fail"},{"issue":"10330","key":"3123_CR13","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","volume":"399","author":"SJ Shah","year":"2022","unstructured":"Shah SJ, Borlaug BA, Chung ES et al (2022) Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet 399(10330):1130\u20131140","journal-title":"Lancet"},{"key":"3123_CR14","unstructured":"The Prophet Trial\u2014Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension. ClinicalTrials.gov Identifier: NCT03022851."},{"key":"3123_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/hc0202.102237","volume":"105","author":"MS Lemler","year":"2002","unstructured":"Lemler MS, Scott WA, Leonard SR et al (2002) Fenestration improves clinical outcome of the Fontan procedure: a prospective, randomized study. Circulation 105:207\u2013212","journal-title":"Circulation"},{"issue":"11","key":"3123_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026087","volume":"11","author":"M Daley","year":"2022","unstructured":"Daley M, Buratto E, King G et al (2022) Impact of Fontan fenestration on long-term outcomes: a propensity score-matched analysis. J Am Heart Assoc 11(11):e026087","journal-title":"J Am Heart Assoc"},{"key":"3123_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ejcts.2006.08.025","volume":"30","author":"M Ono","year":"2006","unstructured":"Ono M, Boethig D, Goerler H et al (2006) Clinical outcome of patients 20 years after Fontan operation\u2014effect of fenestration on late morbidity. Eur J Cardiothorac Surg 30:923\u2013929","journal-title":"Eur J Cardiothorac Surg"},{"key":"3123_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ccd.21045","volume":"69","author":"H Vyas","year":"2007","unstructured":"Vyas H, Driscoll DJ, Cabalka AK et al (2007) Results of transcatheter Fontan fenestration to treat protein losing enteropathy. Catheter Cardiovasc Interv 69:584\u2013589","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"3123_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/ejcts\/ezab298","volume":"61","author":"M Schafstedde","year":"2021","unstructured":"Schafstedde M, Nordmeyer S, Schleiger A et al (2021) Persisting and reoccurring cyanosis after Fontan operation is associated with increased late mortality. Eur J Cardiothorac Surg 61(1):54\u201361","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03123-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-023-03123-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03123-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:04:44Z","timestamp":1721127884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-023-03123-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3123"],"URL":"https:\/\/doi.org\/10.1007\/s00246-023-03123-y","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the authors have nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guidelines on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008, and has been approved by the institutional committee. The patients and their families gave their consent for publication of the cases.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}